These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30911178)

  • 1. Pharmacological convergence reveals a lipid pathway that regulates C. elegans lifespan.
    Chen AL; Lum KM; Lara-Gonzalez P; Ogasawara D; Cognetta AB; To A; Parsons WH; Simon GM; Desai A; Petrascheck M; Bar-Peled L; Cravatt BF
    Nat Chem Biol; 2019 May; 15(5):453-462. PubMed ID: 30911178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice.
    Ramesh D; Gamage TF; Vanuytsel T; Owens RA; Abdullah RA; Niphakis MJ; Shea-Donohue T; Cravatt BF; Lichtman AH
    Neuropsychopharmacology; 2013 May; 38(6):1039-49. PubMed ID: 23303065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.
    Yesilyurt O; Cayirli M; Sakin YS; Seyrek M; Akar A; Dogrul A
    Arch Dermatol Res; 2016 Jul; 308(5):335-45. PubMed ID: 27126057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
    Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
    Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
    Wiebelhaus JM; Grim TW; Owens RA; Lazenka MF; Sim-Selley LJ; Abdullah RA; Niphakis MJ; Vann RE; Cravatt BF; Wiley JL; Negus SS; Lichtman AH
    J Pharmacol Exp Ther; 2015 Feb; 352(2):195-207. PubMed ID: 25398241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
    Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
    Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048).
    Aaltonen N; Kedzierska E; Orzelska-Górka J; Lehtonen M; Navia-Paldanius D; Jakupovic H; Savinainen JR; Nevalainen T; Laitinen JT; Parkkari T; Gynther M
    J Pharmacol Exp Ther; 2016 Oct; 359(1):62-72. PubMed ID: 27451409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597.
    Crow JA; Bittles V; Borazjani A; Potter PM; Ross MK
    Biochem Pharmacol; 2012 Nov; 84(9):1215-22. PubMed ID: 22943979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice.
    Kamimura R; Hossain MZ; Unno S; Ando H; Masuda Y; Takahashi K; Otake M; Saito I; Kitagawa J
    J Oral Sci; 2018 Mar; 60(1):37-44. PubMed ID: 29503395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.
    Gamage TF; Ignatowska-Jankowska BM; Muldoon PP; Cravatt BF; Damaj MI; Lichtman AH
    Drug Alcohol Depend; 2015 Jan; 146():7-16. PubMed ID: 25479915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase.
    Aaltonen N; Savinainen JR; Ribas CR; Rönkkö J; Kuusisto A; Korhonen J; Navia-Paldanius D; Häyrinen J; Takabe P; Käsnänen H; Pantsar T; Laitinen T; Lehtonen M; Pasonen-Seppänen S; Poso A; Nevalainen T; Laitinen JT
    Chem Biol; 2013 Mar; 20(3):379-90. PubMed ID: 23521796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2.
    Martínez-Torres S; Cutando L; Pastor A; Kato A; Sakimura K; de la Torre R; Valjent E; Maldonado R; Kano M; Ozaita A
    Brain Behav Immun; 2019 Oct; 81():399-409. PubMed ID: 31251974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.
    Muldoon PP; Chen J; Harenza JL; Abdullah RA; Sim-Selley LJ; Cravatt BF; Miles MF; Chen X; Lichtman AH; Damaj MI
    Br J Pharmacol; 2015 Feb; 172(3):869-82. PubMed ID: 25258021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.
    Lysenko LV; Kim J; Henry C; Tyrtyshnaia A; Kohnz RA; Madamba F; Simon GM; Kleschevnikova NE; Nomura DK; Ezekowitz RA; Kleschevnikov AM
    PLoS One; 2014; 9(12):e114521. PubMed ID: 25474204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
    Ignatowska-Jankowska B; Wilkerson JL; Mustafa M; Abdullah R; Niphakis M; Wiley JL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2015 May; 353(2):424-32. PubMed ID: 25762694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase.
    Miceli M; Casati S; Allevi P; Berra S; Ottria R; Rota P; Branchini BR; Ciuffreda P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.